Tukysa may be a patient-friendly option as a first line maintenance treatment for HER2-positive breast cancer, as Dr. Erika Hamilton explained.
Dr. Erika Hamilton
Advertisement
Hamilton is a board-certified medical oncologist at SCRI Oncology and the director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, where she specializes in breast and gynecologic cancer treatment and research.
Articles by Dr. Erika Hamilton
Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
Advertisement
Latest Updated Articles
How Patients Can Find the Latest Breast Cancer Treatment UpdatesPublished: July 16th 2025 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Given Months to Live, She’s Now a Five-Year Glioblastoma Survivor
2
Uveal Melanoma Guide: An Overview From Diagnosis to Treatment and Beyond
3
My Three-Time Cancer Journey
4
Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management
5